Calcium sequestration by the sarcoplasmic reticulum in heart failure
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Time for primary review 39 days. Myocardial contraction and relaxation are dependent upon the rise and fall of cytosolic [Ca2+] in cardiac myocytes. The release and sequestration of Ca2+ by the sarcoplasmic reticulum are the principal mechanisms through which this occurs. During relaxation, Ca2+ is actively transported from the cytosol into the sarcoplasmic reticulum; during contraction, this sequestered Ca2+ is passively released into the cytosol through ryanodine-sensitive Ca2+ channels. Because of the dependence of contraction and relaxation upon ATP-dependent Ca2+ sequestration by the sarcoplasmic reticulum, the possibility that an impairment in this process contributes to the pathophysiology of heart failure has been the focus of a large body of research over the past two decades. While there seems to be a general agreement that ATP-dependent Ca2+ sequestration by the sarcoplasmic reticulum is impaired in failing human myocardium, there remains a fairly intense controversy regarding the molecular aetiology of this impairment. In this review, the rationale underlying the experimental approaches to this issue in animal models and human tissues and the conclusions that can be drawn from their results are examined. Ca2+ accumulation by cardiac sarcoplasmic reticulum occurs through the activity of SERCA2, a 105 kDa Ca2+- and Mg2+-dependent ATPase that transports Ca2+ from the cytosol to the lumen of the sarcoplasmic reticulum [1–3]. The Km of SERCA2 for Ca2+ in sarcoplasmic reticulum-enriched vesicles isolated from human left ventricular myocardium is 0.63–0.68 μM, a value which falls within the range of cytosolic Ca2+ concentrations that have been measured in intact cardiac myocytes during relaxation and contraction (0.1–1.0 μM), while the Hill coefficient is 1.6–1.7 [4, 5]. The rate of ATP-dependent Ca2+ transport by the sarcoplasmic reticulum is thus sensitive to small changes in cytosolic [Ca2+] concentrations within the physiologic range. When cytosolic [Ca2+] rises to a value exceeding Km following its release from the sarcoplasmic reticulum, the rate of Ca2+ sequestration by sarcoplasmic reticulum rises to a near-maximal level. As Ca2+ sequestration progresses during relaxation, the reduction in cytosolic [Ca2+] lowers the rate of Ca2+ accumulation until a low diastolic cytosolic [Ca2+] is restored. It is important to appreciate, therefore, that SERCA2 activity determines not only the rate and extent of relaxation, but also the rate and amplitude of contraction, since these are determined by the amount of Ca2+ sequestered by the sarcoplasmic reticulum and the Ca2+ gradient between the sarcoplasmic reticulum and the cytosol at the time Ca2+ release occurs. The activity of SERCA2 is modulated through its interaction with phospholamban, a pentamer comprised of five identical 6 kDa (52 amino acid) monomers [6, 7]. In its unphosphorylated form, phospholamban binds SERCA2 and inhibits Ca2+ transport activity, principally by decreasing affinity (increasing Km) for Ca2+ but also probably by decreasing Vmax[8]. Phosphorylation of phospholamban by any of several protein kinases — among them cAMP-dependent protein kinase, a membrane-associated calmodulin-dependent protein kinase and protein kinase C — blocks the interaction between phospholamban and SERCA2 and relieves this inhibition (Fig. 1) [9–20]. While numerous proteins involved in contraction and relaxation are substrates for cAMP-dependent protein kinase, phosphorylation of phospholamban and the resulting de-inhibition of SERCA2 appears to be the principal molecular mechanism for the inotropic and lusitropic effects of β-adrenergic receptor agonists. The most convincing evidence comes from experiments comparing myocardial responses to isoprenaline in normal mice and in mice in whom the gene for phospholamban has been ablated [21]. In normal mice, rates of contraction and relaxation are relatively low in the absence of isoprenaline and are increased dose-dependently in its presence. In phospholamban-deficient mice, rates of contraction and relaxation are as high in the absence of isoprenaline as they are in normal mice in its presence, and are not increased upon exposure to isoprenaline. These observations are entirely consistent with a mechanism in which unphosphorylated phospholamban inhibits SERCA2 activity, and in which this inhibition is overcome by activation of cAMP-dependent protein kinase and its phosphorylation of phospholamban. (In contrast, the chronotropic response to isoprenaline is preserved in phospholamban-deficient mice, implying that a separate molecular mechanism is responsible for this response.) Regulation of SERCA2 activity by phospholamban. When unphosphorylated, phospholamban (PL) binds to SERCA2, raising Km and possibly lowering Vmax. Phosphorylation blocks this interaction and relieves this inhibition. Ca2+ accumulation may also be subject to regulation by cytosolic proteins. Inhibitory activity toward SERCA2 has been found in a
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,327
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Gwathmey, J. K., Copelas, L., MacKinnon, R., Schoen, F. J., Feldman, M. D., Grossman, W., & Morgan, J. P. (1987) · Circulation Research · doi:10.1161/01.res.61.1.70 · Cited by 924
Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Hasenfuss, G., Reinecke, H., Studer, R., Meyer, M., Pieske, B., Holtz, J., Holubarsch, C., Posival, H., Just, H., & Drexler, H. (1994) · Circulation Research · doi:10.1161/01.res.75.3.434 · Cited by 781
Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
JBeuckelmann, D., MNäbauer, & EErdmann (1992) · Circulation · Cited by 662
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure.
Studer, R., Reinecke, H., Bilger, J., Eschenhagen, T., Böhm, M., Hasenfuss, G., Just, H., Holtz, J., & Drexler, H. (1994) · Circulation Research · doi:10.1161/01.res.75.3.443 · Cited by 633
Beuckelmann, D. J., Näbauer, M., & Erdmann, E. (1992) · Circulation · doi:10.1161/01.cir.85.3.1046 · Cited by 600
Altered myocardial force-frequency relation in human heart failure.
Mulieri, L. A., Hasenfuss, G., Leavitt, B., Allen, P. D., & Alpert, N. R. (1992) · Circulation · doi:10.1161/01.cir.85.5.1743 · Cited by 597
Cited by
Electrophysiological remodeling in hypertrophy and heart failure
Tomaselli, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00017-6 · Cited by 748
Pathophysiology of heart failure
Schwinger, R. H. G. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-302 · Cited by 428
Hoch, B., Meyer, R., Hetzer, R., Krause, E.-G., & Karczewski, P. (1999) · Circulation Research · doi:10.1161/01.res.84.6.713 · Cited by 328
Schwinger, R. H. G., Münch, G., Bölck, B., Karczewski, P., Krause, E.-G., & Erdmann, E. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0897 · Cited by 287
Lips, D. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00829-1 · Cited by 172
Metadata
- Authors
- Movsesian, M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Movsesian, M
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02
- Volume
- 37
- Issue
- 2
- Pages
- 352-359
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2147086185
- Cited by
- 49
- References
- 97
- Citations by year
- 2024: 3 · 2022: 3 · 2021: 1 · 2017: 2 · 2015: 1 · 2012: 1
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- heart failure, sarcoplasmic reticulum, calcium sequestration, SERCA2, Ca2+-ATPase, ryanodine receptor, calcium release channel, calcium handling, cardiomyocytes, intracellular calcium, ATP-dependent calcium transport, animal models of heart failure, sarcoplasmic reticulum calcium stores
- MeSH terms
- Phospholamban, Adenosine Triphosphate, Animals, Calcium, Calcium-Binding Proteins, Heart Failure, Humans, Models, Cardiovascular, Sarcoplasmic Reticulum, Ca(2+) Mg(2+)-ATPase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcium sequestration by the sarcoplasmic reticulum in heart failure. https://app.cochat.ai/papers/10.1016/s0008-6363(97)00259-9
- The paper
- Movsesian, M. (1998). Calcium sequestration by the sarcoplasmic reticulum in heart failure. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(97)00259-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.